Most Clicked StoriesMore >


Pfizer's abuse-deterrent opioid painkiller wins FDA nod

FDLI SmartBrief | Aug 22, 2016

Pfizer's abuse-deterrent Troxyca ER, or oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules, has been approved by the FDA to manage severe pain that requires continuous long-term opioid treatment and for which alternative treatments are inadequate. The painkiller is formulated in pellets with sequestered naltrexone hydrochloride in the core, surrounded by oxycodone hydrochloride. Seeking Alpha (free registration) (08/20)


Janssen's depression drug gets FDA breakthrough status

FDLI SmartBrief | Aug 18, 2016

FDA fast-tracks treatment for Alzheimer's from AstraZeneca, Lilly

FDLI SmartBrief | Aug 23, 2016

FDA: Chinese drugmaker manipulated API quality control data

FDLI SmartBrief | Aug 18, 2016

Pfizer's products from India plant banned in EU due to GMP deficiencies

FDLI SmartBrief | Aug 22, 2016

Senator asks Mylan to justify EpiPen price hike

FDLI SmartBrief | Aug 24, 2016

List of medical events for pharmacovigilance issued by EMA

FDLI SmartBrief | Aug 22, 2016

Medical device industry reaches deal with FDA on user fee program

FDLI SmartBrief | Aug 24, 2016

Final guidances related to benefit-risk determinations released by FDA

FDLI SmartBrief | Aug 24, 2016

New cholesterol drugs are overpriced, researchers say

FDLI SmartBrief | Aug 18, 2016


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Advertising & Promotion Conference, Sept. 27-28, Washington, D.C.

FDLI SmartBrief | Aug 24, 2016

Food Advertising, Labeling and Litigation Conference, Sept. 14-15, Washington, D.C.

FDLI SmartBrief | Aug 24, 2016

Introduction to Food Law and Regulation Course, Sept. 22-23, San Francisco, Calif.

FDLI SmartBrief | Aug 23, 2016

Introduction to Tobacco Law and Regulation Course, Oct. 26, Washington, D.C.

FDLI SmartBrief | Aug 23, 2016

Advertising & Promotion Conference, Sept. 27-28, Washington, D.C.

FDLI SmartBrief | Aug 22, 2016




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.